focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 96.00
Bid: 95.00
Ask: 97.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.105%)
Open: 96.00
High: 96.00
Low: 96.00
Prev. Close: 96.00
MVI Live PriceLast checked at -
Marwyn Value Investors is an Investment Trust

To achieve long-term capital appreciation through its investment in the Master Fund primarily by focusing in mid cap businesses headquartered in the UK, Europe or North America.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AdvancedAdvT Potential Merger

7 Jan 2022 14:48

RNS Number : 8234X
Marwyn Value Investors Limited
07 January 2022
 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

 

LEI: 213800L5751QTTVEA774

 

7 January 2022

 

 

Marwyn Value Investors Limited (the "Company" or "MVIL")

AdvancedAdvT Potential Merger

 

AdvancedAdvT Limited ("AdvT") has today announced that following its acquisition of 12,000,000 ordinary shares in M&C Saatchi Plc ("M&C"), representing c.9.82% of the issued share capital of M&C, it has confirmed that it is interested in exploring a share exchange merger between AdvT and M&C. There is no certainty that any formal offer for M&C will be forthcoming, nor as to the terms of any such formal offer.

 

AdvT's announcement can be viewed at https://www.londonstockexchange.com/news-article/ADVT/potential-merger/15278661 .

 

The Marwyn Funds1 collectively own 20,525,000 ordinary shares and 525,000 ordinary warrants in AdvT. As at 17 December 2021, being the latest available published Net Asset Value ("NAV") information for the Company, the investment in AdvT represents the following for each of the Company's issued share classes:

 

Share class

Look-through NAV value (£m)

% of NAV

Ordinary shares

16.35

16.8%

2016 Realisation shares

Nil

Nil

2021 Realisation shares

0.11

16.8%

 

1 comprises Marwyn Value Investors LP, Marwyn Value Investors II LP and MVI II Co-Invest LP

 

 

Company enquiries:

Company Secretary - Aztec Financial Services (Jersey) Limited

Katrina Boult / Jenny Keen

Telephone: 01534 833000

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

Corporate Broker - Liberum Capital Limited

Chris Clarke / Owen Matthews

Telephone: 0203 100 2200

 

Marwyn Value Investors Limited is a closed-ended investment company on the London Stock Exchange Specialist Fund Segment - a fully regulated market for professional, institutional and sophisticated investors. Current investments through its underlying funds include Zegona Communications plc, AdvancedAdvT Limited, Marwyn Acquisition Company plc, Marwyn Acquisition Company II Limited, Marwyn Acquisition Company III Limited, MAC Alpha Limited and the operating business of Le Chameau.

For further information see http://www.marwynvalue.com. Neither the content of the Company's website, nor at https://www.londonstockexchange.com/news-article/ADVT/potential-merger/15278661, nor the content on any website accessible from hyperlinks on its website or any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "expects", "believes", "estimates", "envisages", "plans", "anticipates", "targets", "aims", "continues", "expects", "intends", "hopes", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include matters that are not facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. A number of factors could cause actual results and developments to differ materially from those expressed or implied by the forward-looking statements. Forward-looking statements contained in this announcement based on past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Subject to any requirement under the Listing Rules, Prospectus Rules, the Disclosure Guidance and Transparency Rules or other applicable legislation or regulation, the Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investors should not place undue reliance on forward-looking statements, which speak only as of the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEALFXELKAEFA
Date   Source Headline
19th Feb 20219:16 amRNSNet Asset Value
19th Feb 20219:09 amRNSNet Asset Value
11th Feb 20214:08 pmRNSNet Asset Value
11th Feb 20214:07 pmRNSNet Asset Value
5th Feb 20219:33 amRNSNet Asset Value
5th Feb 20218:59 amRNSNet Asset Value
28th Jan 20214:04 pmRNSNet Asset Value
28th Jan 20217:00 amRNSInterim Dividend to Ordinary Shareholders
27th Jan 20213:23 pmRNSDirector/PDMR Shareholding
22nd Jan 202110:25 amRNSNet Asset Value
15th Jan 202112:49 pmRNSNet Asset Value
15th Jan 202112:48 pmRNSNet Asset Value
15th Jan 202112:00 pmRNSImplementation of Distribution Policy
15th Jan 202111:22 amRNSResult of EGM
5th Jan 20212:04 pmRNSNet Asset Value
5th Jan 20212:03 pmRNSNet Asset Value
31st Dec 20208:00 amRNSAppointment of Vin Murria OBE to MAC I
23rd Dec 20205:41 pmRNSNet Asset Value
23rd Dec 20205:40 pmRNSNet Asset Value
21st Dec 202011:59 amRNSNotification of major interests in shares
18th Dec 20205:20 pmRNSExchange Procedure
16th Dec 20203:34 pmRNSDistribution Policy Implementation & Notice of EGM
10th Dec 20204:23 pmRNSNet Asset Value
10th Dec 20204:22 pmRNSNet Asset Value
4th Dec 20208:11 amRNSLaunch of three new acquisition companies
4th Dec 20207:00 amRNSNet Asset Value
4th Dec 20207:00 amRNSNet Asset Value
3rd Dec 202011:12 amRNSResult of AGM
26th Nov 20206:17 pmRNSNet Asset Value
26th Nov 20206:16 pmRNSNet Asset Value
25th Nov 20207:00 amRNSTransaction in Own Shares
20th Nov 20202:12 pmRNSNet Asset Value
20th Nov 20202:11 pmRNSNet Asset Value
17th Nov 202010:28 amRNSNotice of Adjourned AGM
16th Nov 202011:06 amRNSNotice of adjournment regarding AGM
16th Nov 20207:00 amRNSTransaction in Own Shares
12th Nov 20204:53 pmRNSNet Asset Value
12th Nov 20204:51 pmRNSNet Asset Value
9th Nov 20203:07 pmRNSNotification of major interests in shares
9th Nov 20207:00 amRNSTransaction in Own Shares
6th Nov 20205:18 pmRNSNet Asset Value
6th Nov 20205:16 pmRNSNet Asset Value
29th Oct 20205:09 pmRNSNet Asset Value
29th Oct 20205:08 pmRNSNet Asset Value
26th Oct 20207:00 amRNSTransaction in Own Shares
23rd Oct 20201:15 pmRNSPartial Cash Redemption of Realisation Shares
23rd Oct 20207:00 amRNSNotice of AGM
22nd Oct 20204:46 pmRNSNet Asset Value
22nd Oct 20204:45 pmRNSNet Asset Value
20th Oct 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.